Mesa Laboratories Inc logo

Mesa Laboratories Inc

2
NAS:MLAB (USA)   Ordinary Shares
$ 115.50 +2.13 (+1.88%) 11:09 PM EST
679.41
P/B:
1.55
Market Cap:
$ 623.01M
Enterprise V:
$ 830.89M
Volume:
33.29K
Avg Vol (2M):
37.09K
Also Trade In:
Volume:
33.29K
Avg Vol (2M):
37.09K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for MLAB ( Mesa Laboratories Inc ) from 1995 to May 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Mesa Laboratories stock (MLAB) PE ratio as of May 05 2024 is 679.41. More Details

Mesa Laboratories Inc (MLAB) PE Ratio (TTM) Chart

To

Mesa Laboratories Inc (MLAB) PE Ratio (TTM) Historical Data

Total 1222
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Mesa Laboratories PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-05 679.4 2024-03-01 643.7
2024-05-03 679.4 2024-02-29 642.3
2024-05-02 666.9 2024-02-28 630.6
2024-05-01 648.1 2024-02-27 633.8
2024-04-30 624.0 2024-02-26 623.7
2024-04-29 620.7 2024-02-23 616.1
2024-04-26 607.0 2024-02-22 617.9
2024-04-25 598.8 2024-02-21 603.9
2024-04-24 614.5 2024-02-20 607.4
2024-04-23 627.2 2024-02-16 604.2
2024-04-22 601.5 2024-02-15 613.4
2024-04-19 592.6 2024-02-14 571.4
2024-04-18 586.0 2024-02-13 534.5
2024-04-17 594.9 2024-02-12 560.8
2024-04-16 602.9 2024-02-09 552.1
2024-04-15 614.4 2024-02-08 549.4
2024-04-12 617.7 2024-02-07 533.1
2024-04-11 616.0 2024-02-06 564.2
2024-04-10 612.1 2024-02-05 584.1
2024-04-09 628.8 2024-02-02 552.9
2024-04-08 624.4 2024-02-01 553.4
2024-04-05 593.6 2024-01-31 538.9
2024-04-04 589.2 2024-01-30 553.2
2024-04-03 587.1 2024-01-29 567.2
2024-04-02 584.7 2024-01-26 558.9
2024-04-01 658.8 2024-01-25 542.1
2024-03-28 645.5 2024-01-24 548.4
2024-03-27 630.9 2024-01-23 547.1
2024-03-26 602.0 2024-01-22 567.0
2024-03-25 587.5 2024-01-19 536.6
2024-03-22 605.9 2024-01-18 533.4
2024-03-21 626.6 2024-01-17 542.9
2024-03-20 614.4 2024-01-16 560.9
2024-03-19 598.7 2024-01-12 564.5
2024-03-18 598.4 2024-01-11 566.7
2024-03-15 594.6 2024-01-10 587.1
2024-03-14 587.4 2024-01-09 600.1
2024-03-13 620.2 2024-01-08 603.2
2024-03-12 626.3 2024-01-05 581.9
2024-03-11 628.4 2024-01-04 592.0
2024-03-08 658.8 2024-01-03 571.4
2024-03-07 671.2 2024-01-02 625.1
2024-03-06 657.6 2023-12-29 616.3
2024-03-05 654.5 2023-12-28 623.5
2024-03-04 660.6 2023-12-27 At Loss

Mesa Laboratories Inc (MLAB) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Mesa Laboratories Inc logo
Mesa Laboratories Inc
NAICS : 334513 SIC : 3823
ISIN : US59064R1095

Share Class Description:

MLAB: Ordinary Shares
Description
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.